Biologics and Advanced Therapies

Risks & contraindications

Comparisons

Highlighted claims

• South Asian patients are prescribed biologics less often, use more corticosteroids, and experience longer delays before starting advanced therapies compared to white patients. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Some patients delayed advanced therapies because they viewed biologics or injectable treatments as signs of severe disease, last-resort options, or steps immediately preceding surgery. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• The belief that intravenous therapies necessarily have more side effects than oral therapies is a misconception that clinicians should address directly. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Some patients feared that starting biologics too soon would accelerate progression toward more serious interventions. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Some patients perceived newer biologic treatments as experimental and worried about being used as test subjects. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada